Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited announced candidates for its Board of Directors and a change in representative director at the 150th Ordinary General Meeting of Shareholders on June 24, 2026. Julie Kim is proposed as new internal director to become Representative Director, President & CEO, succeeding Christophe Weber who will retire, with new external directors Bruce Broussard, Koichiro Kimura, and Paul Stoffels proposed.

Key Takeaways